Ticker
MGNXCompany Name
MACROGENICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Cash and Equivalents | Cash to Assets Ratio |
---|---|---|---|
6/30/2025 | $ 245.42M | $ 130.69M | 53.25% |
3/31/2025 | $ 224.56M | $ 145.57M | 64.82% |
12/31/2024 | $ 261.65M | $ 182.84M | 69.88% |
9/30/2024 | $ 264.49M | $ 179.63M | 67.91% |
6/30/2024 | $ 201.14M | $ 83.93M | 41.73% |
3/31/2024 | $ 248.28M | $ 80.36M | 32.36% |
12/31/2023 | $ 298.42M | $ 100.96M | 33.83% |
9/30/2023 | $ 339.97M | $ 89.9M | 26.44% |
6/30/2023 | $ 305.65M | $ 108.76M | 35.58% |
3/31/2023 | $ 343.5M | $ 224.26M | 65.29% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CashnEq / Assets
(=) Cash to Assets
Cash to Assets for MACROGENICS INC is calculated as follows: CashnEq [ $ 201.64M ] / Assets [ $ 374.38M ]
(=) Cash to Assets [ 53.86% ]
Minimum
Jun 30, 2022
Maximum
Dec 31, 2024
Average
Median
filtered constituents | 3.94K |
---|---|
min | 0% |
max | 40.76% |
average | 9.78% |
median | 6.42% |
std | 9.53% |